A case of gouty arthritis following percutaneous radiofrequency ablation for hepatocellular carcinoma
- PMID: 20135729
- PMCID: PMC2817069
- DOI: 10.3748/wjg.v16.i6.778
A case of gouty arthritis following percutaneous radiofrequency ablation for hepatocellular carcinoma
Abstract
Percutaneous radiofrequency thermal ablation (RFA) is considered an effective technique for providing local control in the majority of Hepatocellular carcinoma (HCC) patients. Although RFA is generally well tolerated, recent studies have reported complications associated with RFA. We describe a case of acute gouty arthritis in a 71-year-old man with chronic renal failure who was treated with RFA for a HCC lesion and who had hepatitis B-associated cirrhosis and mild renal insufficiency. Regular surveillance of the patient detected a 3.5 cm HCC lesion. Because the patient had declined surgery, RFA was chosen for therapy. On the third post-procedural day, the laboratory results showed increases in his uric acid and potassium levels, which were compatible with a tumor lysis syndrome. On the 6th post-procedural day, the patient complained of new right knee pain. Subsequent joint aspiration revealed monosodium urate monohydrate crystals. We made the diagnosis of acute gouty arthritis arising from tumor lysis and liver infarction caused by HCC ablation, which was aggravated by acute renal insufficiency. After adequate hydration and administration of oral colchicines, the patient's right knee pain subsided and the uric acid serum level returned to normal. This is the first described case of acute gouty arthritis after RFA for a HCC lesion in a patient with underlying chronic renal insufficiency. To avoid hyperuricemia and an acute attack of gout after RFA therapy for HCC, early identification of patients at risk is warranted, such as those with a large tumor, rapid tumor growth, and renal insufficiency, and preventative measures should be considered.
Figures



Similar articles
-
Management of acute and chronic gouty arthritis: present state-of-the-art.Drugs. 2004;64(21):2399-416. doi: 10.2165/00003495-200464210-00003. Drugs. 2004. PMID: 15481999 Review.
-
[Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].Zhonghua Zhong Liu Za Zhi. 2015 Dec;37(12):933-7. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26887624 Chinese.
-
Colchicine-responsive protracted gouty arthritis with systemic inflammatory reactions.Mod Rheumatol. 2014 May;24(3):540-3. doi: 10.3109/14397595.2013.874732. Epub 2014 Feb 18. Mod Rheumatol. 2014. PMID: 24533551
-
Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?Eur J Gastroenterol Hepatol. 2008 Mar;20(3):196-201. doi: 10.1097/MEG.0b013e3282f1cc4a. Eur J Gastroenterol Hepatol. 2008. PMID: 18301300
-
[Therapy of hyperuricemia and gout].Wien Med Wochenschr. 1997;147(16):382-7. Wien Med Wochenschr. 1997. PMID: 9446417 Review. German.
Cited by
-
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate-Case Report.J Clin Med. 2022 Sep 22;11(19):5548. doi: 10.3390/jcm11195548. J Clin Med. 2022. PMID: 36233415 Free PMC article.
-
Acute gouty arthritis following percutaneous cryoablation of renal cell carcinoma.Radiol Case Rep. 2019 Sep 26;14(11):1432-1437. doi: 10.1016/j.radcr.2019.09.003. eCollection 2019 Nov. Radiol Case Rep. 2019. PMID: 31695832 Free PMC article.
-
Successful treatment of acute tumor lysis syndrome associated with transcatheter chemoembolization with large hepatocellular carcinomas: two case reports.Transl Cancer Res. 2020 Oct;9(10):6516-6521. doi: 10.21037/tcr-20-1158. Transl Cancer Res. 2020. PMID: 35117259 Free PMC article.
References
-
- Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology. 2004;127:S248–S260. - PubMed
-
- Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5:550–560. - PubMed
-
- Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl. 2004;10:S91–S97. - PubMed
-
- Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–451. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical